News

25 January 2022

Iterative Scopes Enters Collaboration to Advance AI and Computer Vision Technologies for Accelerating IBD Clinical Trials

Read full story

20 January 2022

ImmPACT Bio Closes $111 Million Series B Financing, Names New Board Chair and New President and CEO, and Updates on Phase 1 Clinical Study in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Read full story

19 January 2022

Iterative Scopes Announces $150 Million Series B to Advance AI-Driven Precision Medicine for Gastroenterology

Read full story

Partner news

18 January 2022

Leyden Labs Licenses Pan-Influenza Antibody from Janssen

Read full story

Partner news

18 January 2022

The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases

Read full story

14 January 2022

Digital Health Leader Verana Health Secures $150M Series E Funding Round

Read full story

Partner news

6 January 2022

TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation

Read full story

Partner news

6 January 2022

i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules

Read full story

Partner news

5 January 2022

SRI International announces collaboration agreement with Janssen

Read full story

Partner news

4 January 2022

Genocea Biosciences Provides Corporate Update

Read full story